A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Sulfamerazine
Alloin
The risk or severity of adverse effects can be increased when Sodium phosphate, dibasic is combined with Alloin.
Sulfamerazine
Konjac mannan
The risk or severity of adverse effects can be increased when Sodium phosphate, dibasic is combined with Konjac mannan.
Sulfamerazine
Emodin
The risk or severity of adverse effects can be increased when Sodium phosphate, dibasic is combined with Emodin.
Sulfamerazine
Calcium polycarbophil
The risk or severity of adverse effects can be increased when Sodium phosphate, dibasic is combined with Calcium polycarbophil.
Sulfamerazine
Oxyphenisatin acetate
The risk or severity of adverse effects can be increased when Sodium phosphate, dibasic is combined with Oxyphenisatin acetate.
Sulfamerazine
Sodium phosphate, dibasic, unspecified form
The risk or severity of adverse effects can be increased when Sodium phosphate, dibasic is combined with Sodium phosphate, dibasic, unspecified form.
Sulfamerazine
Potassium sulfate
The risk or severity of adverse effects can be increased when Potassium sulfate is combined with Sodium phosphate, dibasic.
Sulfamerazine
Sodium ascorbate
The risk or severity of adverse effects can be increased when Sodium ascorbate is combined with Sodium phosphate, dibasic.
Sulfamerazine
Magnesium glycinate
The risk or severity of adverse effects can be increased when Magnesium glycinate is combined with Sodium phosphate, dibasic.
Sulfamerazine
Sodium fluorophosphate
The risk or severity of adverse effects can be increased when Sodium fluorophosphate is combined with Sodium phosphate, dibasic.
Sulfamerazine
Dipotassium phosphate
The risk or severity of adverse effects can be increased when Dipotassium phosphate is combined with Sodium phosphate, dibasic.
Sulfamerazine
Plantago ovata seed
The risk or severity of adverse effects can be increased when Plantago ovata seed is combined with Sodium phosphate, dibasic.
Sulfamerazine
Zinc
The risk or severity of adverse effects can be increased when Zinc is combined with Sodium phosphate, dibasic.
Sulfamerazine
Deacetylbisacodyl
The risk or severity of adverse effects can be increased when Deacetylbisacodyl is combined with Sodium phosphate, dibasic.
Sulfamerazine
Plecanatide
The risk or severity of adverse effects can be increased when Plecanatide is combined with Sodium phosphate, dibasic.
Sulfamerazine
Linaclotide
The risk or severity of adverse effects can be increased when Linaclotide is combined with Sodium phosphate, dibasic.
Sulfamerazine
Bisoxatin
The risk or severity of adverse effects can be increased when Bisoxatin is combined with Sodium phosphate, dibasic.
Sulfamerazine
Phenolphthalein
The risk or severity of adverse effects can be increased when Phenolphthalein is combined with Sodium phosphate, dibasic.
Sulfamerazine
Sodium tartrate
The risk or severity of adverse effects can be increased when Sodium tartrate is combined with Sodium phosphate, dibasic.
Sulfamerazine
Pentaerithrityl
The risk or severity of adverse effects can be increased when Pentaerithrityl is combined with Sodium phosphate, dibasic.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3